Cargando…
Hedgehog Pathway Inhibitors against Tumor Microenvironment
Targeting the hedgehog (HH) pathway to treat aggressive cancers of the brain, breast, pancreas, and prostate has been ongoing for decades. Gli gene amplifications have been long discovered within malignant glioma patients, and since then, inhibitors against HH pathway-associated molecules have succe...
Autores principales: | Gampala, Silpa, Yang, Jer-Yen |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8619966/ https://www.ncbi.nlm.nih.gov/pubmed/34831357 http://dx.doi.org/10.3390/cells10113135 |
Ejemplares similares
-
Targeting the Hedgehog Pathway in Pediatric Medulloblastoma
por: Huang, Sherri Y., et al.
Publicado: (2015) -
Activation of AMPK sensitizes medulloblastoma to Vismodegib and overcomes Vismodegib‐resistance
por: Gampala, Silpa, et al.
Publicado: (2021) -
Sonic Hedgehog Signaling in Organogenesis, Tumors, and Tumor Microenvironments
por: Jeng, Kuo-Shyang, et al.
Publicado: (2020) -
Hedgehog signaling in gastrointestinal carcinogenesis and the gastrointestinal tumor microenvironment
por: Zhang, Jinghui, et al.
Publicado: (2021) -
Activation of the integrated stress response (ISR) pathways in response to Ref-1 inhibition in human pancreatic cancer and its tumor microenvironment
por: Mijit, Mahmut, et al.
Publicado: (2023)